Teligent (TLGTQ) 8-K Other Events

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 13, 2005
__________________________________________________________
IGI, INC.
(Exact Name of Registrant as Specified in Charter)
___________________________________________________________
Delaware		001-08568	01-0355758
(State or Other Jurisdiction		(Commission File Number)	(I.R.S. Employer
of Incorporation)			Identification Number)
105 Lincoln Avenue
Buena, New Jersey 08310
(Address of Principal Executive Offices) (Zip Code)
(856) 697-1441
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[   ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[   ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[   ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

<PAGE>  

Item 8.01.  Other Events
On December 13, 2005, IGI, Inc. (the "Company") issued a press release disclosing the that it extended its exclusive license from Novavax, Inc. for the use of Novasome® lipid vesicle encapsulation technology, micellar nano-particles, and the Ultrasponge® Technology until December 2015. A copy of the Company's press release is attached as Exhibit 99.1 hereto.
Item 9.01.  Financial Statements and Exhibits.
(c)  Exhibits
Exhibit Number	Description
99.1	IGI, Inc. Press Release dated December 13, 2005.

<PAGE>

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
	IGI, INC.
	By:	/s/ Frank Gerardi
		Frank Gerardi
		Chairman & Chief Executive Officer
Date:  December 19, 2005

<PAGE>  

EXHIBIT INDEX
Exhibit
Number	Description
99.1	IGI, Inc. Press Release dated December 13, 2005.

<PAGE>